These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
210 related items for PubMed ID: 23199398
1. Challenges in the treatment of chronic hepatitis C in the HIV/HCV-coinfected patient. Rodríguez-Torres M. Expert Rev Anti Infect Ther; 2012 Oct; 10(10):1117-28. PubMed ID: 23199398 [Abstract] [Full Text] [Related]
2. Focus on drug interactions: the challenge of treating hepatitis C virus infection with direct-acting antiviral drugs in the HIV-positive patient. Rodríguez-Torres M. Curr Opin Infect Dis; 2013 Feb; 26(1):50-7. PubMed ID: 23242341 [Abstract] [Full Text] [Related]
3. Directly acting antivirals for hepatitis C and antiretrovirals: potential for drug-drug interactions. Seden K, Back D. Curr Opin HIV AIDS; 2011 Nov; 6(6):514-26. PubMed ID: 22001895 [Abstract] [Full Text] [Related]
4. Future of hepatitis C therapy: development of direct-acting antivirals. Dore GJ, Matthews GV, Rockstroh J. Curr Opin HIV AIDS; 2011 Nov; 6(6):508-13. PubMed ID: 21897228 [Abstract] [Full Text] [Related]
5. Challenges and opportunities for hepatitis C drug development in HIV-hepatitis C virus-co-infected patients. Soriano V, Sherman KE, Rockstroh J, Dieterich D, Back D, Sulkowski M, Peters M. AIDS; 2011 Nov 28; 25(18):2197-208. PubMed ID: 21866039 [Abstract] [Full Text] [Related]
6. [Prevalence of potential interactions between antiretroviral therapy and boceprevir or telaprevir in human immunodeficiency virus-hepatitis C virus coinfected patients]. González-Colominas E, Solà R, Barrantes-González M, Salas E. Enferm Infecc Microbiol Clin; 2013 May 28; 31(5):350-1. PubMed ID: 23182365 [No Abstract] [Full Text] [Related]
8. New directly acting antivirals for hepatitis C: potential for interaction with antiretrovirals. Seden K, Back D, Khoo S. J Antimicrob Chemother; 2010 Jun 28; 65(6):1079-85. PubMed ID: 20335191 [Abstract] [Full Text] [Related]
9. Management and treatment of chronic hepatitis C in HIV patients. Barreiro P, Vispo E, Labarga P, Soriano V. Semin Liver Dis; 2012 May 28; 32(2):138-46. PubMed ID: 22760653 [Abstract] [Full Text] [Related]
10. HIV and hepatitis C coinfection. Matthews GV, Dore GJ. J Gastroenterol Hepatol; 2008 Jul 28; 23(7 Pt 1):1000-8. PubMed ID: 18707597 [Abstract] [Full Text] [Related]
11. Coinfection with human immunodeficiency virus and hepatitis C virus: challenges and therapeutic advances. Insights from the Society of Infectious Diseases Pharmacists. Deming P, McNicholl IR. Pharmacotherapy; 2011 Apr 28; 31(4):357-68. PubMed ID: 21449625 [Abstract] [Full Text] [Related]
12. Will direct-acting antivirals make a difference in HIV-HCV coinfected patients? Bruno R, Fagiuoli S, Sacchi P. Expert Rev Anti Infect Ther; 2011 Sep 28; 9(9):699-701. PubMed ID: 21905777 [No Abstract] [Full Text] [Related]
16. Human immunodeficiency virus and hepatitis C virus coinfection: epidemiology, natural history, therapeutic options and clinical management. Verucchi G, Calza L, Manfredi R, Chiodo F. Infection; 2004 Feb 28; 32(1):33-46. PubMed ID: 15007741 [Abstract] [Full Text] [Related]
17. Hepatitis C virus-RNA clearance in HIV-coinfected patients with chronic hepatitis C treated with pegylated interferon plus ribavirin. Soriano V, Núñez M, Camino N, Maida I, Barreiro P, Romero M, Martin-Carbonero L, Garcia-Samaniego J, González-Lahoz J. Antivir Ther; 2004 Aug 28; 9(4):505-9. PubMed ID: 15456081 [Abstract] [Full Text] [Related]